MedTrace Logo

Surgical Management of Stage-2 MRONJ With Transplantation of HAM

NCT04967963 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2025-04-13

No results posted yet for this study

Summary

Medication-related osteonecrosis of the jaw (MRONJ) is a drug adverse reaction and there is no consensus for the treatment of MRONJ. The aim of this study is to evaluate the mucosal coverage using HAM after sequestrectomy in patients with stage-2 MRONJ.

Conditions

  • Medication Related Osteonecrosis of the Jaw
  • Oral Surgery

Interventions

PROCEDURE

HAM

Transplantation of HAM

Sponsors & Collaborators

  • Trakya University

    lead OTHER

Principal Investigators

  • F. Gülfeşan Çanakçi · Trakya University, Faculty of Dentistry

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-15
Primary Completion
2021-09-15
Completion
2022-03-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04967963 on ClinicalTrials.gov